Nomura Holdings Inc. Grows Position in Prenetics Global Limited (NASDAQ:PRE)

Nomura Holdings Inc. boosted its holdings in Prenetics Global Limited (NASDAQ:PRE) by 140.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 193,963 shares of the company’s stock after acquiring an additional 113,288 shares during the quarter. Nomura Holdings Inc. owned about 2.12% of Prenetics Global worth $1,146,000 as of its most recent filing with the SEC.

Prenetics Global Stock Down 0.2 %

PRE opened at $5.95 on Thursday. The firm has a market cap of $54.37 million, a P/E ratio of -1.24 and a beta of -0.16. Prenetics Global Limited has a 52 week low of $2.85 and a 52 week high of $14.55. The business’s fifty day simple moving average is $5.31 and its 200 day simple moving average is $4.94.

Prenetics Global (NASDAQ:PRE) last posted its quarterly earnings data on Monday, April 1st. The company reported ($0.52) EPS for the quarter. The company had revenue of $5.43 million for the quarter. Prenetics Global had a negative net margin of 193.60% and a negative return on equity of 11.15%. As a group, equities analysts expect that Prenetics Global Limited will post -3.59 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Cantor Fitzgerald lowered their target price on Prenetics Global from $10.00 to $9.00 and set an “overweight” rating on the stock in a report on Thursday, April 4th.

Prenetics Global Profile

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.